Načítá se...
Novel stroke risk reduction in atrial fibrillation: left atrial appendage occlusion with a focus on the Watchman closure device
Atrial fibrillation (AF) remains an important clinical problem with severe complications such as stroke, which especially harms those with risk factors as calculated by the CHADS(2) or CHA(2)DS(2)-VASc. Until now, no therapy has proven 100% effective against AF. Since the left atrial appendage (LAA)...
Uloženo v:
| Vydáno v: | Vasc Health Risk Manag |
|---|---|
| Hlavní autoři: | , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Dove Medical Press
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5345987/ https://ncbi.nlm.nih.gov/pubmed/28293114 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/VHRM.S89213 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|